Chronic low dose arsenic exposure preferentially perturbs mitotic phase of the cell cycle S Ganapathy, J Liu, R Xiong, T Yu, A Makriyannis, C Chen Genes & Cancer 10 (1-2), 39, 2019 | 19 | 2019 |
Low doses of arsenic, via perturbing p53, promotes tumorigenesis S Ganapathy, P Li, J Fagman, T Yu, J Lafontant, G Zhang, C Chen Toxicology and Applied Pharmacology 306, 98-104, 2016 | 19 | 2016 |
Chromium IV exposure, via Src/Ras signaling, promotes cell transformation S Ganapathy, P Li, J Lafontant, R Xiong, T Yu, G Zhang, C Chen Molecular Carcinogenesis 56 (7), 1808-1815, 2017 | 13 | 2017 |
A lethal synergy induced by phellinus linteus and camptothecin11 in colon cancer cells T Yu, S Ganapathy, L Shen, B Peng, SH Kim, A Makriyannis, C Chen Oncotarget 9 (5), 6308, 2018 | 10 | 2018 |
Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells S Ganapathy, B Peng, L Shen, T Yu, J Lafontant, P Li, R Xiong, ... Oncotarget 8 (19), 30992, 2017 | 8 | 2017 |
Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C S Ganapathy, JB Fagman, L Shen, T Yu, X Zhou, W Dai, A Makriyannis, ... Oncotarget 7 (51), 84326, 2016 | 5 | 2016 |
Study of the Lethal Synergy of Phellinus linteus and CPT11 in Colon Cancer T Yu Northeastern University, 2018 | 1 | 2018 |
Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells S Ganapathy, B Peng, L Shen, T Yu, J Lafontant, P Li, R Xiong, ... Oncotarget 14, 148, 2023 | | 2023 |
PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistance S Ganapathy, J Liu, T Yu, R Xiong, Q Zhang, A Makriyannis, C Chen Aging (Albany NY) 14 (4), 1678, 2022 | | 2022 |
Corrigendum to" Low doses of arsenic, via perturbing p53, promotes tumorigenesis"[Toxicol. Appl. Pharmacol.(2016) 98-104]. S Ganapathy, P Li, J Fagman, T Yu, J Lafontant, G Zhang, C Chen Toxicology and Applied Pharmacology 314, 118-118, 2016 | | 2016 |
Cancer Biology and Clinical Oncology S Ganapathy, T Yu, L Shen, B Peng, SH Kim, C Chen | | |